Moore Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Moore Capital Management's LLY Position: Q1 2026 in Review
Moore Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 11,000 shares — an estimated $11.8M sold.
Moore Capital Management first reported a position in LLY in Q1 2016 and held it in 14 quarters. The position peaked at $31.5M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Moore Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Moore Capital Management sold 11,000 Eli Lilly shares in Q1 2026, an estimated $11.8M.
- Moore Capital Management first reported a position in Eli Lilly in Q1 2016 and held it in 14 quarters.
- Moore Capital Management's Eli Lilly position peaked at $31.5M in Q4 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.